Veru Inc. Still Has Serious Growth To Realize

May 19, 2022 3:41 AM ETVeru Inc. (VERU)16 Comments
Stocks Telegraph profile picture
Stocks Telegraph


  • Veru Inc. is a Florida-based drug developer, which focuses primarily on developing cancer-treatment drugs as well as its sexual health division.
  • This year, the company hit a stroke of luck upon discovering its cancer treatment candidate, Sabizabulin is a highly efficacious and safe treatment against ARDS in later-stage Covid-19 patients.
  • Veru’s financials show an increase in its periodic losses, given its increasing R&D costs, which it funds from the profits of its marketed FC2 (female condom) products.
  • VERU stands impressively against a number of its peers, which suggests an undervaluation, as well as a low degree of credit risk.
finger poking colourful shapes

We Are/DigitalVision via Getty Images

Veru Inc. (NASDAQ:VERU) is a stock that looks set to see growth in the coming months and potentially explosive growth in the coming years. For this reason, I believe the stock is a clear buy. It has managed to adopt a relatively

This article was written by

Stocks Telegraph profile picture
Stocks Telegraph is a dynamic team of financial market wizards with over 40 years of combined experience covering US stock markets. We hope to cover a wide range of stocks, asset classes, and investment strategies with a primary emphasis on what we perceive to be hidden gems scattered across the financial markets. Our articles integrate both top-down and bottom-up research methodologies, drawing upon detailed company-specific financials and macroeconomic analysis. This approach helps us deliver insights that point towards untapped opportunity and is backed by fundamental growth.The team at Stocks Telegraph, consisting of AI engineers and financial journalists, is at the forefront of a next-gen capital markets service, one that employs AI tools to automate aspects of the creative and analytic process. This encompasses all stages from initial research, and tracking stock data and news, to the creation of insightful reports.The brilliant minds at Stocks Telegraph are currently developing a robust AI tool to perform stock sentiment analysis through scanning digital content and news headlines. The goal of this tool is the prediction of stock movements by analyzing news headline tones and assessing market dynamics by utilizing data analytical functions.Our pipeline also includes plans to develop an automated tool capable of generating accessible earning insights, within minutes of official earning reports being published.

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (16)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.